Readers may be interested in the following upcoming events.
October 17-19, Washington, DC
ABA – Fifth Annual National Institute on the Foreign Corrupt Practices Act. See here for complete program details.
Curriculum topics include: SEC- civil enforcement update: trends and significant developments; compliance and internal investigations: a case study; the trial of an FCPA case: pitfalls and pratfalls; and real world application of Dodd-Frank whistleblower protections.
I am pleased to be participating in a panel on Friday, Oct. 19th regarding promises and pitfalls of anti-bribery risk assessment. The other panelists are Robert Amaee (Covington & Burling, London and the U.K. Expert for FCPA Professor), Tyler Hodgson (Borden Ladner Gervais, Toronto) William Jacobson (Weatherford International) and Joseph Spinelli (Navigant). The panel will be moderated by Gregory Esslinger (FTI Consulting).
October 27, New York City
The 91st Annual Meeting of the American Branch of the International Law Association (“International Law Weekend”) will take place at Fordham Law School October 25-27. See here for complete program details. As evident from the program details, International Law Weekend touches upon a diverse set of legal and policy issues.
On Saturday October 27th a panel discussion will take place titled “Bribery Prosecutions for Profit? Policy and Practical Implications.”
Bruce Bean (Michigan State University Law School) will chair and moderate the panel and joining me in tackling this provocative issue will be Richard Alderman (former Director of the U.K. Serious Fraud Office), Michael Madigan (Orrick), Kathleen Harris (Arnold & Porter) and Daniel Chow (Moritz College of Law, Ohio State University).
November 15-16, Baltimore, MD
The University of Maryland Francis King Carey School of Law and the Maryland Journal of International Law will host a symposium titled “Extraterritoriality Post-Kiobel: International & Comparative Perspectives.” Kiobel refers to the case the Supreme Court recently heard in which an issue is the extraterritorial application of the Alien Tort Claims Act.
The symposium will bring together a diverse group of international lawyers, scholars, and practitioners to critically discuss the issue of extraterritoriality from a range of international and comparative legal perspectives. The symposium will address four interrelated themes: (1) whether States have jurisdiction under international law to adjudicate civil claims, including transitory tort claims, arising in the territory of foreign States; (2) the impact of the case on related questions involving the extraterritorial application of domestic law and treaty obligations in the ongoing war on terror; (3) Kiobel’s likely impact on wider issues of extraterritoriality and globalization in such areas of law as antitrust, corporate liability and choice of law; and (4) the more enduring significance of the case as a matter of general international legal theory.
I will be presenting on November 16th on a panel concerning “Extraterritoriality in a Globalized World” and will discuss the issue of extraterritoriality in the context of the FCPA. My presentation and forthcoming paper is titled “The Foreign Corrupt Practices Act, Foreign Actors, and De Facto Extraterritoriality.”
December 10-12, Philadelphia, PA
Pharmaceutical Anti-Corruption Compliance event sponsored by Hanson Wade. See here for complete program details.
On December 10th, I will conduct a three hour pre-conference workshop titled “What Every Pharma Professional Needs to Know About the FCPA.” Later in the day, Tom Fox (FCPA Compliance and Ethics Blog) will conduct an additional workshop titled “New Approaches to Creating, Developing and Embedding a Compliance Culture Within Your Organization.”
During the conference, on December 11th, I will present “Understanding the FCPA’s New Era.”
As noted in this prior post “The Origins and Prominence of a Theory,” the pharma industry has been specifically impacted by the enforcement theory that employees of certain foreign health-care systems are “foreign officials.”
*****
I hope to see FCPA Professor readers at these events.